Monday January 27, 2020

Pharma sector calls for drug prices to build in real-world value

The pharmaceutical industry wants future negotiations on drug pricing to include the extent to which drugs prevent costly hospital stays and details of other societal benefits they generate

Susan Mitchell

Deputy Editor and Health Editor

@susmitchellsbp
17th November, 2019
Aidan Lynch: the IPHA president believes price needs to be looked at as an end-to-end cost rather than in isolation Pic: Bryan Meade

The pharmaceutical industry wants future negotiations on drug pricing to include the extent to which drugs prevent costly hospital stays and details of other societal benefits they generate.

Aidan Lynch, general manager of GSK and president of the Irish Pharmaceutical Healthcare Association (IPHA), which represents the industry, said: “If we could look, not just at price in isolation, but at an end-to-end cost, such as bed days and reduced staff required – that type of...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

The three main parties’ election manifestos are big on promises but short on details when it comes to reforming health, and it’s sure to cause headaches for any incoming government

Susan Mitchell | 1 day ago

Board earmarked funds to enhance claims management and save money over life of project

Peter O'Dwyer | 1 day ago

The genetic data harvesting company posted the results as calls were made for the Irish government to appoint a genomics medicine guru

Killian Woods | 1 day ago